About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Fecal microbiota transplantation delivery through

Company: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Mechanism: Mechanism not yet reported
Route: Oral
Recruiting trials: None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026

Trial details

Completed NCT NCT06368895

Fecal Microbiota Transplantation by Oral Capsules for Hepatic Encephalopathy Treatment

Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 33 participants Est. completion 2024-10-31 1 site Stand-alone

Other conditions: Hepatic Encephalopathy, Dysbiosis
View official trial listing →

Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

ClinicalTrials.gov — NCT06368895

Also known as: Fecal microbiota transplantation delivery through, Fecal microbiota transplantation delivery through oral capsules

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.